- Merck CEO cautions Congress on imposing limits on Chinese dealmakingMerck CEO Rob Davis said he has warned Congress and the Trump administration that if they cut off or hamper US-China dealmaking, the US could lose its status as the world's biotech leader. China-…Endpoints · 1d ago↗ source
- Scancell plans Neuphoria merger; AstraZeneca wins EU nod for cancer drugScancell to merge into Neuphoria: Scancell plans to take over Neuphoria Therapeutics' Nasdaq listing {$NEUP} and change the ticker to SCLT. The company eyes up to $89 million in equity and ...Endpoints · 1d ago↗ source
- A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribingHas a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare disease? Find out on this week's episode of…